Patents by Inventor Laura CONTI

Laura CONTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11040223
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: June 22, 2021
    Assignee: Agilvax Inc.
    Inventors: Federica Cavallo, Stefania Lanzardo, Laura Conti, John P. O'Rourke, Federica Pericle
  • Publication number: 20200316147
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Application
    Filed: March 16, 2020
    Publication date: October 8, 2020
    Inventors: Federica CAVALLO, Stefania LANZARDO, Laura CONTI, John P. O'ROURKE, Federica PERICLE
  • Patent number: 10588953
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Grant
    Filed: December 18, 2016
    Date of Patent: March 17, 2020
    Assignee: AGILVAX, INC.
    Inventors: Federica Cavallo, Stefania Lanzardo, Laura Conti, John P. O'Rourke, Federica Pericle
  • Publication number: 20180360935
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Application
    Filed: December 18, 2016
    Publication date: December 20, 2018
    Inventors: Federica CAVALLO, Stefania LANZARDO, Laura CONTI, John P. O'ROURKE, Federica PERICLE